These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 27798456)
1. Future considerations based on the information from Barrter's and Gitelman's syndromes. Alfandary H; Landau D Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):9-13. PubMed ID: 27798456 [TBL] [Abstract][Full Text] [Related]
2. DNA analysis of renal electrolyte transporter genes among patients suffering from Bartter and Gitelman syndromes: summary of mutation screening. Urbanová M; Reiterová J; Stěkrová J; Lněnička P; Ryšavá R Folia Biol (Praha); 2011; 57(2):65-73. PubMed ID: 21631963 [TBL] [Abstract][Full Text] [Related]
3. Molecular pathophysiology of Bartter's and Gitelman's syndromes. Koulouridis E; Koulouridis I World J Pediatr; 2015 May; 11(2):113-25. PubMed ID: 25754753 [TBL] [Abstract][Full Text] [Related]
4. Bartter and Gitelman syndromes: Questions of class. Besouw MTP; Kleta R; Bockenhauer D Pediatr Nephrol; 2020 Oct; 35(10):1815-1824. PubMed ID: 31664557 [TBL] [Abstract][Full Text] [Related]
5. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes. Shaer AJ Am J Med Sci; 2001 Dec; 322(6):316-32. PubMed ID: 11780689 [TBL] [Abstract][Full Text] [Related]
6. Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins. Wagner CA; Loffing-Cueni D; Yan Q; Schulz N; Fakitsas P; Carrel M; Wang T; Verrey F; Geibel JP; Giebisch G; Hebert SC; Loffing J Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1373-80. PubMed ID: 18322017 [TBL] [Abstract][Full Text] [Related]
7. Abnormal reabsorption of Na+/CI- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman's syndrome. Colussi G; Rombolà G; Brunati C; De Ferrari ME Am J Nephrol; 1997; 17(2):103-11. PubMed ID: 9096439 [TBL] [Abstract][Full Text] [Related]
8. Salt-Losing Tubulopathies in Children: What's New, What's Controversial? Kleta R; Bockenhauer D J Am Soc Nephrol; 2018 Mar; 29(3):727-739. PubMed ID: 29237739 [TBL] [Abstract][Full Text] [Related]
10. Thiazide-sensitive Na+-Cl- cotransporter: genetic polymorphisms and human diseases. Wang L; Dong C; Xi YG; Su X Acta Biochim Biophys Sin (Shanghai); 2015 May; 47(5):325-34. PubMed ID: 25841442 [TBL] [Abstract][Full Text] [Related]
11. Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome. Lee JW; Lee J; Heo NJ; Cheong HI; Han JS J Korean Med Sci; 2016 Jan; 31(1):47-54. PubMed ID: 26770037 [TBL] [Abstract][Full Text] [Related]
12. The genetic spectrum of Gitelman(-like) syndromes. Schlingmann KP; de Baaij JHF Curr Opin Nephrol Hypertens; 2022 Sep; 31(5):508-515. PubMed ID: 35894287 [TBL] [Abstract][Full Text] [Related]
13. Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension. Melander O; Orho-Melander M; Bengtsson K; Lindblad U; Râstam L; Groop L; Hulthén UL Hypertension; 2000 Sep; 36(3):389-94. PubMed ID: 10988270 [TBL] [Abstract][Full Text] [Related]
14. Paradoxes in magnesium transport in type 1 Bartter's syndrome and Gitelman's syndrome: a modeling analysis. Dutta P; Layton AT Am J Physiol Renal Physiol; 2024 Sep; 327(3):F386-F396. PubMed ID: 38991009 [TBL] [Abstract][Full Text] [Related]